Literature DB >> 21119582

Lipid peroxidation is elevated in female patients with chronic fatigue syndrome.

Snezana Brkic1, Slavica Tomic, Daniela Maric, Aleksandra Novakov Mikic, Vesna Turkulov.   

Abstract

BACKGROUND: Chronic fatigue syndrome is a debilitating disease of unclear cause and pathogenesis. It affects mostly women from lower socioeconomic classes. There is mounting evidence that oxidative stress, specifically lipid peroxidation (LPO) contributes to the disease process. We investigated levels of LPO and its possible consequences for these patients. MATERIAL/
METHODS: Forty women aged 15-45 years who fulfilled the 1994 Centers for Disease Control's diagnostic criteria for chronic fatigue syndrome (CFS) with no comorbidities were recruited and were age matched to a control group of 40 healthy women. Levels of total cholesterol (TC), triglycerides (TG), LDL cholesterol (LDLc), HDL cholesterol (HDLc), and malondialdehyde (MDA) levels were measured.
RESULTS: Although initial statistical analyses showed no differences between groups (P=.345), when subdivided according to the level of MDA, a difference was found in the subgroup of high-level MDA (P=.034). There was a negative correlation between HDLc and MDA levels (r=0.3; P=.046), a positive correlation between TG and MDA levels (r=0.4; P=.006), and lower levels of HDL cholesterol in the CFS group (P=.036).
CONCLUSIONS: High levels of MDA, positively correlated with TG and lower HDL levels, might be indicative of proatherogenic events in female CFS patients, a group not otherwise considered a risk for atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21119582

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  12 in total

1.  Metabolomics study of fatigue in patients with rheumatoid arthritis naïve to biological treatment.

Authors:  Izabella Surowiec; Clara Gram Gjesdal; Grete Jonsson; Katrine Brække Norheim; Torbjörn Lundstedt; Johan Trygg; Roald Omdal
Journal:  Rheumatol Int       Date:  2016-01-23       Impact factor: 2.631

Review 2.  Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications.

Authors:  Gerwyn Morris; George Anderson; Michael Berk; Michael Maes
Journal:  Mol Neurobiol       Date:  2013-06-13       Impact factor: 5.590

3.  Cerebral vascular control is associated with skeletal muscle pH in chronic fatigue syndrome patients both at rest and during dynamic stimulation.

Authors:  Jiabao He; Kieren G Hollingsworth; Julia L Newton; Andrew M Blamire
Journal:  Neuroimage Clin       Date:  2013-01-05       Impact factor: 4.881

4.  Multivitamin mineral supplementation in patients with chronic fatigue syndrome.

Authors:  Daniela Maric; Snezana Brkic; Slavica Tomic; Aleksandra Novakov Mikic; Tatjana Cebovic; Vesna Turkulov
Journal:  Med Sci Monit       Date:  2014-01-14

5.  Heat shock proteins and chronic fatigue in primary Sjögren's syndrome.

Authors:  Kjetil Bårdsen; Mari Mæland Nilsen; Jan Terje Kvaløy; Katrine Brække Norheim; Grete Jonsson; Roald Omdal
Journal:  Innate Immun       Date:  2016-02-25       Impact factor: 2.680

Review 6.  Predicting disease onset in clinically healthy people.

Authors:  Harold I Zeliger
Journal:  Interdiscip Toxicol       Date:  2017-05-17

7.  Oxidative Stress is a Convincing Contributor to Idiopathic Chronic Fatigue.

Authors:  Jin-Seok Lee; Hyeong-Geug Kim; Dong-Soo Lee; Chang-Gue Son
Journal:  Sci Rep       Date:  2018-08-27       Impact factor: 4.379

8.  Low-density lipoprotein, its susceptibility to oxidation and the role of lipoprotein-associated phospholipase A2 and carboxyl ester lipase lipases in atherosclerotic plaque formation.

Authors:  Paweł Burchardt; Jakub Zurawski; Bartosz Zuchowski; Tomasz Kubacki; Dawid Murawa; Krzysztof Wiktorowicz; Henryk Wysocki
Journal:  Arch Med Sci       Date:  2013-02-10       Impact factor: 3.318

9.  Oxidative and Nitrosative Stress and Immune-Inflammatory Pathways in Patients with Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS).

Authors:  Gerwyn Morris; Michael Maes
Journal:  Curr Neuropharmacol       Date:  2014-03       Impact factor: 7.363

Review 10.  Understanding Muscle Dysfunction in Chronic Fatigue Syndrome.

Authors:  Gina Rutherford; Philip Manning; Julia L Newton
Journal:  J Aging Res       Date:  2016-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.